Glioma

How Reirradiation is Becoming a Key Strategy in Recurrent Glioma Care – ESTRO

European Society for Radiotherapy and Oncology (ESTRO) shared a post on X:

ESTRO25 reirradiation report:

From new ESTRO-EANO guidelines to insights from GLIAA and RTOG 1205 trials, and survival data in paediatric DIPG/DMG, explore how reirradiation is becoming a key strategy in recurrent glioma care.”

Read Further.

How Reirradiation is Becoming a Key Strategy in Recurrent Glioma Care - ESTRO

More posts featuring European Society for Radiotherapy and Oncology.